Cholinesterase inhibitors (such as rivastigmine, donepezil, and galantamine) and N–methyl D–Aspartate receptor antagonists (such as memantine) may be considered pharmacological treatments for cognitive decline [34], but their improvements for functional impairment still require further study. Here, BCHE is linked to Mental deterioration.